30 December 2019

25 December 2019 Two studies recently presented at the recent San Antonio Breast Cancer Symposium focused on a subtype of breast cancer known as Her2/neu over-expressed, which include up to 20% of breast cancers. In these tumors, the gene that codes for the Her2 protein receptor has more than the usual number of copies. These tumors […]

24 December 2019 (updated 6 February 2020) A recently published study evaluated the association between hair products and breast cancer risk. The researchers surveyed women enrolled in the Sister Study – these women had a sister with a history of breast cancer but had not been diagnosed themselves. The study group included over 46,000 women, ages 35-74, enrolled between […]

19 December 2019 A study recently published in the Journal of Clinical Oncology* found that the use of some vitamins and supplements before or during chemotherapy treatment for breast cancer was associated with increased recurrence and mortality rates. Vitamins and supplements may interfere with or prevent the desired chemotherapy or radiation therapy effect of cell death, so […]

13 December 2019 For women at high risk for breast cancer, tamoxifen and raloxifene have both been shown to be effective in reducing risk by approximately 30-40%. A recent small study found that low dose (5mg) of tamoxifen is also effective for risk reduction. In post-menopausal women with a history of breast cancer, it is […]

12 December 2019 A study presented at the San Antonio Breast Cancer Symposium last week provides more evidence to support the use of accelerated partial breast irradiation (APBI) after lumpectomy in selected patients with breast cancer. Radiation after lumpectomy typically treats the entire breast (whole breast irradiation, WBI) and is usually administered daily for 3-6 […]

28 November 2019 A study recently published in the New England Journal of Medicine* suggests that the use of breast MRI in addition to mammograms in women with extremely dense breast can improve the rate of “interval cancer” detection. Interval cancers are those that occur after an apparently normal mammogram, but prior to the next […]